Trial intelligence / Profile preview

High-flow oxygen therapy for high-risk patients undergoing digestive endoscopy under deep sedation (ENDOALF trial)

2026-525766-21-01Phase 4Authorised

Sponsor: Hospital Universitario Rio Hortega
Start: Jun 2026
Modality: Small Molecules
Countries: 1

Overview

Phase 4, randomised trial of oxygen in anoxemia (2 arms), sponsored by Hospital Universitario Rio Hortega. Primary endpoint: Composite cardiorespiratory safety events. Planned start Jun 2026; status: authorised.

Drugs

oxygen

Conditions

anoxemia

Beyond the preview

Go deeper on 2026-525766-21-01.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2026-525766-21-01.